190+


Publications

1,200+


Impact factors

1,300+


Citations

Publication Highlights


  1. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild type advanced NSCLC. Journal for ImmunoTherapy of Cancer. 2020 Jan;8(1). pii: e000376. doi: 10.1136/jitc-2019-000376.
  2. Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors. Journal of Medical Genetics.2020 Apr 13. pii: jmedgenet-2019-106546. doi: 10.1136/jmedgenet-2019-106546.
  3. Widespread and Functional RNA Circularization in Localized Prostate Cancer. Cell. 2019 Feb 7;176(4):831-843.e22. doi: 10.1016/j.cell.2019.01.025.
  4. Distribution of NRG1 Gene Fusions in a Large Population of Chinese Patients with NSCLC. Journal of Thoracic Oncology. 2019 Dec;14(12):e263-e266. doi: 10.1016/j.jtho.2019.07.012.
  5. Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti-PD-(L)1 Therapies in Non-Small-Cell Lung Cancer. Clinical Cancer Research. 2019 Aug 15;25(16):5015-5026. doi: 10.1158/1078-0432.CCR-19-0585.
  6. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics. 2019 Jul 28;9(19):5532-5541. doi: 10.7150/thno.34070.
  7. Developing more sensitive genomic approaches to detect radioresponse in precision radiation oncology: From tissue DNA analysis to circulating tumor DNA. Cancer Letters. 2020 Mar 1;472:108-118. doi: 10.1016/j.canlet.2019.12.004.
  8. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer. Cancer. 2019 Oct 15;125(20):3535-3544. doi: 10.1002/cncr.32372.
  9. Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer. Gut. 2019 Jul;68(7):1152-1161. doi: 10.1136/gutjnl-2018-316522.
  10. EGFR and ERBB2 Germline Mutations in Chinese Lung cancer Patients and Their Roles in Genetic Susceptibility to Cancer. Journal of Thoracic Oncology. 2019 Apr;14(4):732-736. doi: 10.1016/j.jtho.2018.12.006.
  11. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain. 2019 Jan 1;142(1):23-34. doi: 10.1093/brain/awy307.
  12. Clinical And Molecular Features Of Acute Promyelocytic Leukemia With Variant Retinoid Acid Receptor Fusions. Haematologica. 2019 May;104(5):e195-e199. doi: 10.3324/haematol.2018.205369.
  13. Investigating novel resistance mechanisms to third generation EGFR TKI osimertinib in non-small cell lung cancer patients using next generation sequencing. Clinical Cancer Research. 2018 Jul 1;24(13):3097-3107. doi: 10.1158/1078-0432.CCR-17-2310.
  14. Circulating Tumor DNA Mutational Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types. Scientific Reports. 2017 Apr 3;7(1):583. doi: 10.1038/s41598-017-00520-1.
  15. The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC. Journal of Thoracic Oncology. 2016 Sep;11(9):1503-10. doi: 10.1016/j.jtho.2016.05.016.